Sec Form 4 Filing - KRAMMER FRANZ @ INVACARE CORP - 2008-08-20

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person KRAMMER FRANZ 2. Issuer Name and Ticker or Trading Symbol INVACARE CORP [ IVC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Mg. Dir. - Invacare Europe (Last) (First) (Middle) ONE INVACARE WAY 3. Date of Earliest Transaction (MM/DD/YY) 08/20/2008 (Street) ELYRIA, OH44035 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (Right to Buy) $ 25.79 08/20/2008 A( 1 ) 4,150 09/30/2009 08/20/2018 Common Shares 4,150 $ 0 46,150 D Employee Stock Option (Right to Buy) $ 25.79 08/20/2008 A( 1 ) 4,150 09/30/2010 08/20/2018 Common Shares 4,150 $ 0 50,300 D Employee Stock Option (Right to Buy) $ 25.79 08/20/2008 A( 1 ) 4,150 09/30/2011 08/20/2018 Common Shares 4,150 $ 0 54,450 D Employee Stock Option (Right to Buy) $ 25.79 08/20/2008 A( 1 ) 4,150 09/30/2012 08/20/2018 Common Shares 4,150 $ 0 58,600 ( 2 ) D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other KRAMMER FRANZ ONE INVACARE WAY ELYRIA, OH44035 Mg. Dir. - Invacare Europe Signatures /s/ Franz Krammer, by Douglas A. Neary his attorney-in-fact pursuant to Power of Attorney dated May 27, 2005 on file with the Commission 08/22/2008 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The reporting person was granted options to purchase Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan in reliance upon an exemption provided under Rule 16b-3. ( 2 )The reporting person holds previously reported options to buy 42,000 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between April 8, 2005 and August 2, 2007, at exercise prices between $22.66 and $44.17 per share, will expire between April 8, 2015 and August 22, 2017 and became or will become exercisable between September 30, 2005 and September 30, 2011.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.